Finance

Beta
Lists
106190:KOSDAQ
High Tech Pharm Co Ltd
₩13,700.00
+0.15%
(+20.00) 1D
Jun 19, 3:30:18 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 106190...
Open
₩13,570
High
₩13,800
Low
₩12,980
Mkt. cap
145.67B
Avg. vol.
56.10K
Volume
75.04K
Dividend
1.09%
Quarterly dividend
₩37
Ex-dividend date
Dec 29, 2025
P/E ratio
16.28
52-wk high
₩25,000
52-wk low
₩10,700
EPS
₩841
Shares outstanding
10.63M
No. of employees
127
Open
₩13,570
High
₩13,800
Low
₩12,980
Mkt. cap
145.67B
Avg. vol.
56.10K
Volume
75.04K
Dividend
1.09%
Quarterly dividend
₩37
Ex-dividend date
Dec 29, 2025
P/E ratio
16.28
52-wk high
₩25,000
52-wk low
₩10,700
EPS
₩841
Shares outstanding
10.63M
No. of employees
127
News stories
From sources across the web
About High Tech Pharm Co Ltd
CEO-
Employees127
Founded1998
Headquarters-
SectorPharmaceutical industry
Websitehtpharm.com
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
23.02B
17.87B
14.04B
14.13B
Cost of goods sold
18.88B
13.06B
9.46B
11.74B
Cost of revenue
18.88B
13.06B
9.46B
11.74B
Research and development expenses
-
-
816.56M
149.93M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
890.59M
867.11M
552.71M
3.29B
Operating expense
925.55M
903.37M
1.41B
3.48B
Total operating expenses
19.80B
13.96B
10.87B
15.22B
Operating income
3.22B
3.91B
3.17B
-1.10B
Other non operating income
885.48M
9.31M
127.18M
58.88M
EBT including unusual items
2.91B
4.61B
3.73B
-376.60M
EBT excluding unusual items
2.88B
4.55B
3.77B
-410.48M
Income tax expense
566.87M
818.46M
573.95M
-109.58M
Effective tax rate
19.49%
17.76%
15.38%
29.10%
Other operating expenses
15.08M
14.62M
15.68M
16.21M
Net income
2.34B
3.79B
3.16B
-267.02M
Net profit margin
10.17%
21.22%
22.50%
-1.89%
Earnings per share
-
-
-
-
Interest and investment income
3.32M
2.72M
4.25M
5.30M
Interest expense
-84.60M
-4.81M
-384.00K
-312.00K
Net interest expenses
-81.28M
-2.09M
3.86M
4.98M
Depreciation and amortization charges
19.87M
21.64M
20.76M
21.29M
EBITDA
4.57B
5.27B
4.55B
297.19M
Gain or loss from assets sale
-3.00M
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer